Abstract

Beer is a popular beverage and some beneficial effects have been attributed to its moderate consumption. We carried out a pilot study to test if beer and non-alcoholic beer consumption modify the levels of a panel of 53 cardiometabolic microRNAs in plasma and macrophages. Seven non-smoker men aged 30–65 with high cardiovascular risk were recruited for a non-randomised cross-over intervention consisting of the ingestion of 500 mL/day of beer or non-alcoholic beer for 14 days with a 7-day washout period between interventions. Plasma and urine isoxanthohumol were measured to assess compliance with interventions. Monocytes were isolated and differentiated into macrophages, and plasma and macrophage microRNAs were analysed by quantitative real-time PCR. Anthropometric, biochemistry and dietary parameters were also measured. We found an increase in plasma miR-155-5p, miR-328-3p, and miR-92a-3p after beer and a decrease after non-alcoholic beer consumption. Plasma miR-320a-3p levels decreased with both beers. Circulating miR-320a-3p levels correlated with LDL-cholesterol. We found that miR-17-5p, miR-20a-5p, miR-145-5p, miR-26b-5p, and miR-223-3p macrophage levels increased after beer and decreased after non-alcoholic beer consumption. Functional analyses suggested that modulated microRNAs were involved in catabolism, nutrient sensing, Toll-like receptors signalling and inflammation. We concluded that beer and non-alcoholic beer intake modulated differentially plasma and macrophage microRNAs. Specifically, microRNAs related to inflammation increased after beer consumption and decreased after non-alcoholic beer consumption.

Highlights

  • Beer is a very popular beverage worldwide, and in Europe

  • We found that fold change (FC) after beer intake was significant in comparison with FC after nonalcoholic beer intake

  • We found that plasma miR-320 levels positively correlated with low-density lipoproteins (LDLs) levels, suggesting that lower circulating miR-320 is associated with a better plasma lipid profile, supporting a potential role of circulating miR-320 as a biomarker of cardiovascular disease (CVD)

Read more

Summary

Introduction

Beer is a very popular beverage worldwide, and in Europe. In 2016, 39 billion and 900 million litres of beer and non-alcoholic beer were produced in the European Union [1]. Beer intake has been suggested to be beneficial for cardiovascular risk factors [5,6,7,8] The mechanism behind this association could be the inhibition of the oxidation of low-density lipoproteins (LDLs), inducible nitric oxide synthase (iNOS), cyclooxygenase 1 and 2 (COX-1) and prostaglandin E [9,10]. Most of these effects have been experimentally assayed in animal models, and with specific components of the beer, mainly polyphenols, and limited evidence in humans exists [7,8,9]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call